Harmonized public data for a personalized cancer-vaccine immunogenicity pipeline: epitope–MHC presentation, immunogenicity labels, thymic & proteomic self references, foreign ligandomes, and HLA population frequencies. Per-patient cohort data is private and excluded here.
| Dataset | Category | Species | MHC | Records | Distinct peptides | Tissue | Source | Feeds |
|---|---|---|---|---|---|---|---|---|
| IEDB epitope–MHC | Presentation | human+mouse | I+II | 1,482,188 | 689,421 | — | IEDB | mhcmatch |
| IEDB epitope–MHC (≥2 refs) | Presentation | human+mouse | I+II | 645,102 | 174,821 | — | IEDB | mhcmatch |
| IEDB immunogenicity | Immunogenicity | human+mouse | I+II | 790,868 | 516,092 | — | IEDB | ipred, public-epitope |
| Neoantigens — tested | Immunogenicity | human | I+II | 525,989 | 491,495 | Tumor | TESLA, NCI, CEDAR, Gfeller, ITSNdb, GBM, VACCIMEL, Bjerregaard | model, ipred |
| Neoantigens — candidates | Immunogenicity | human | I | 1,355,926 | 1,344,070 | Tumor | NCI | model |
| TCGA neoantigens | Immunogenicity | human | I | 2,244,779 | 1,948,737 | Tumor | TCGA | model |
| HLA population freqs | HLA frequencies | — | — | 7,171 | — | Population | AFND | model |
| Thymus self-peptidome | Self reference | human | I+II | 53,878 | 53,878 | Thymus | HLA Ligand Atlas | seqtree |
| Thymus expression | Self reference | — | — | 10,493 | — | Thymus | HPA, HLA Ligand Atlas | seqtree |
| Human proteome | Self reference | human | — | 147,506 | — | — | UniProt | seqtree |
| Mouse proteome | Self reference | mouse | — | 54,857 | — | — | UniProt | seqtree |
| Bacterial + viral proteomes | Foreign reference | foreign | — | 16,467 | — | Microbial / viral | UniProt | seqtree |
| Viral ligandome (IEDB) | Foreign reference | human+mouse | I+II | 82,368 | 44,993 | Viral | IEDB | seqtree |
| Pan-viral ORFs (GSE272406) | Foreign reference | — | — | 5,673 | — | Viral | GSE272406 | seqtree |
| Cancer-testis antigens | Presentation | — | — | 393 | — | Tumor | tsarina | mhcmatch |